AVMA news
AVMA updates include new technology entity, PVME open for comment
The AVMA rang in the new year with a record high 105,000 members, strong financials, and a slate of initiatives for the year ahead that address…
AVMA news
Vaccine hesitancy gives some US dog, cat owners cold feet
The connection between attitudes toward human and pet vaccines and how those of some people are changing is forcing veterinary professionals to more…
AVMA news
AVMA Board chair addresses challenges to VCPR, advocacy efforts
Dr. Charles Lemme was elected chair of the AVMA Board of Directors this past July during AVMA Convention 2023 in Denver. About halfway through his…
AVMA news
USP revised compounding standards go into effect
Revised compounding standards from the United States Pharmacopeia (USP) became effective November 1 after 12 years of work. According to the USP, the…
blog
Key legislation approved to support animal drug development
The federal government has approved continued collection of user fees that support veterinary drug development—legislation that AVMA’s then-president…
AVMA applauds passage of legislation to enhance the review process of new and generic animal drugs
In the latest government spending bill, Congress included and passed legislation that reauthorizes the Animal Drug User Fee Act (ADUFA) and the Animal…
AVMA news
Telehealth bill advances in California Senate
California Assembly Bill 1399 passed the California Senate Appropriations Committee on September 1. The bill would allow a…
AVMA news
House Committee advances AVMA-backed xylazine language
The Administration announced its national coordinated response on July 11 to fight the deadly combination of illicit xylazine mixed with fentanyl.
blog
Advocacy update: Illicit xylazine, retirement saving, and budget wins
What's happening in Washington, D.C., that affects you? The AVMA's Capitol Hill update outlines some of the most recent developments.
AVMA news
AVMA webinars help veterinarians navigate opioid epidemic
Three new drug-related webinars are available on demand on AVMA Axon to help veterinarians meet their state’s continuing education (CE) requirements…
AVMA news
Ditching the blame game: Effectively responding to medical errors
A session on veterinary medical errors at the 2023 Student AVMA (SAVMA) Symposium discussed what the most common errors are, the importance of…
AVMA news
Canine parvovirus treatment receives conditional approval
The U.S. Department of Agriculture has granted a conditional license for the Canine Parvovirus Monoclonal Antibody—Elanco's first monoclonal antibody…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
AVMA news
Zoetis receives $15.3M grant to improve livestock health in Africa
Zoetis announced in March that the company received a $15.3 million grant from the Bill & Melinda Gates Foundation to further develop and integrate…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
blog
Compounding: How do new rules affect you?
The FDA says it will start phasing in inspectional activities in April for its new guidance on compounding from bulk drug substances. Here’s what…
AVMA news
FDA conditionally approves first drug for acute onset of pancreatitis in dogs
The Food and Drug Administration announced Nov. 15 that it has granted conditional approval of Panoquell-CA1, or fuzapladib sodium for injection, to…
AVMA news
FDA extends educational period for new policy on compounding animal drugs from bulk drug substances
The Food and Drug Administration has delayed enforcement of its finalized guidance regarding compounding animal drugs from bulk drug substances.
Compounding from bulk drug substances
Learn about GFI #256, which clarifies the circumstances under which FDA does not intend to pursue enforcement action for compounding animal drugs from…
JAVMA news
In video, FDA urges adverse event reporting
Whenever an animal drug is linked to an adverse event—in an animal or a person—Food and Drug Administration officials want to know about it.
JAVMA news
Public health experts say now is the time to advocate on drug resistance
As the threat of the pandemic fades, Dr. Morrison said, the threat of antimicrobial resistance persists.
JAVMA news
CAPC warns care delays may leave pets vulnerable to parasites
Leaders of the Companion Animal Parasite Council recommend that veterinarians consider sending reminders to clients earlier about parasite protection…
JAVMA news
‘There are only safe anesthetists’
Speakers at the AVMA Virtual Convention 2020 discussed how to improve safety for cats and dogs undergoing anesthesia. Speakers at the American Animal…
blog
CDC announces priorities for distributing COVID-19 vaccine
A new interim guide issued by the U.S. Centers for Disease Control and Prevention (CDC) suggests that veterinary team members may have access to an…
blog
Explore cannabis topics in depth with experts
AVMA's first-ever symposium on veterinary cannabis will provide a 360-degree perspective, presented directly by key leaders in research, practice and…